Global Mycoplasma Testing in Clinical Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Mycoplasma Testing in Clinical Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
  • 1.2.2 PCR
  • 1.2.3 ELSA
  • 1.2.4 Enzymatic Methods
  • 1.2.5 DNA Staining
• 1.3 Market by Application
  • 1.3.1 Global Mycoplasma Testing in Clinical Market Growth Rate by Application: 2017 VS 2021 VS 2028
  • 1.3.2 Cell Line Testing
  • 1.3.3 Virus Testing
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Market Perspective

• 2.1 Global Mycoplasma Testing in Clinical Market Size (2017-2028)
• 2.2 Mycoplasma Testing in Clinical Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
• 2.3 Global Mycoplasma Testing in Clinical Market Size by Region (2017-2022)
• 2.4 Global Mycoplasma Testing in Clinical Market Size Forecast by Region (2023-2028)
• 2.5 Global Top Mycoplasma Testing in Clinical Countries Ranking by Market Size

3 Mycoplasma Testing in Clinical Competitive by Company

• 3.1 Global Mycoplasma Testing in Clinical Revenue by Players
  • 3.1.1 Global Mycoplasma Testing in Clinical Revenue by Players (2017-2022)
  • 3.1.2 Global Mycoplasma Testing in Clinical Market Share by Players (2017-2022)
• 3.2 Global Mycoplasma Testing in Clinical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Company Covered: Ranking by Mycoplasma Testing in Clinical Revenue
• 3.4 Global Mycoplasma Testing in Clinical Market Concentration Ratio
  • 3.4.1 Global Mycoplasma Testing in Clinical Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Mycoplasma Testing in Clinical Revenue in 2021
• 3.5 Global Mycoplasma Testing in Clinical Key Players Head office and Area Served
• 3.6 Key Players Mycoplasma Testing in Clinical Product Solution and Service
• 3.7 Date of Enter into Mycoplasma Testing in Clinical Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Global Mycoplasma Testing in Clinical Breakdown Data by Type

• 4.1 Global Mycoplasma Testing in Clinical Historic Revenue by Type (2017-2022)
• 4.2 Global Mycoplasma Testing in Clinical Forecasted Revenue by Type (2023-2028)

5 Global Mycoplasma Testing in Clinical Breakdown Data by Application

• 5.1 Global Mycoplasma Testing in Clinical Historic Market Size by Application (2017-2022)
• 5.2 Global Mycoplasma Testing in Clinical Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Mycoplasma Testing in Clinical Revenue by Company (2020-2022)
• 6.2 North America Mycoplasma Testing in Clinical Revenue by Type (2017-2028)
• 6.3 North America Mycoplasma Testing in Clinical Revenue by Application (2017-2028)
• 6.4 North America Mycoplasma Testing in Clinical Revenue by Country (2017-2028)
  • 6.4.1 U.S.
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Mycoplasma Testing in Clinical Revenue by Company (2020-2022)
• 7.2 Europe Mycoplasma Testing in Clinical Revenue by Type (2017-2028)
• 7.3 Europe Mycoplasma Testing in Clinical Revenue by Application (2017-2028)
• 7.4 Europe Mycoplasma Testing in Clinical Revenue by Country (2017-2028)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia

8 Asia Pacific

• 8.1 Asia Pacific Mycoplasma Testing in Clinical Revenue by Company (2020-2022)
• 8.2 Asia Pacific Mycoplasma Testing in Clinical Revenue by Type (2017-2028)
• 8.3 Asia Pacific Mycoplasma Testing in Clinical Revenue by Application (2017-2028)
• 8.4 Asia Pacific Mycoplasma Testing in Clinical Revenue by Region (2017-2028)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 India
  • 8.4.5 Australia
  • 8.4.6 Taiwan
  • 8.4.7 Indonesia
  • 8.4.8 Thailand
  • 8.4.9 Malaysia
  • 8.4.10 Philippines
  • 8.4.11 Vietnam

9 Latin America

• 9.1 Latin America Mycoplasma Testing in Clinical Revenue by Company (2020-2022)
• 9.2 Latin America Mycoplasma Testing in Clinical Revenue by Type (2017-2028)
• 9.3 Latin America Mycoplasma Testing in Clinical Revenue by Application (2017-2028)
• 9.4 Latin America Mycoplasma Testing in Clinical Revenue by Country (2017-2028)
  • 9.4.1 Mexico
  • 9.4.2 Brazil
  • 9.4.3 Argentina

10 Middle East and Africa

• 10.1 Middle East and Africa Mycoplasma Testing in Clinical Revenue by Company (2020-2022)
• 10.2 Middle East and Africa Mycoplasma Testing in Clinical Revenue by Type (2017-2028)
• 10.3 Middle East and Africa Mycoplasma Testing in Clinical Revenue by Application (2017-2028)
• 10.4 Middle East and Africa Mycoplasma Testing in Clinical Revenue by Country (2017-2028)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 U.A.E

11 Company Profiles

• 11.1 Sartorius AG
  • 11.1.1 Sartorius AG Company Details
  • 11.1.2 Sartorius AG Business Overview
  • 11.1.3 Sartorius AG Mycoplasma Testing in Clinical Products and Services
  • 11.1.4 Sartorius AG Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022)
  • 11.1.5 Sartorius AG Mycoplasma Testing in Clinical SWOT Analysis
  • 11.1.6 Sartorius AG Recent Developments
• 11.2 MERCK KGAA
  • 11.2.1 MERCK KGAA Company Details
  • 11.2.2 MERCK KGAA Business Overview
  • 11.2.3 MERCK KGAA Mycoplasma Testing in Clinical Products and Services
  • 11.2.4 MERCK KGAA Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022)
  • 11.2.5 MERCK KGAA Mycoplasma Testing in Clinical SWOT Analysis
  • 11.2.6 MERCK KGAA Recent Developments
• 11.3 ELITechGROUP
  • 11.3.1 ELITechGROUP Company Details
  • 11.3.2 ELITechGROUP Business Overview
  • 11.3.3 ELITechGROUP Mycoplasma Testing in Clinical Products and Services
  • 11.3.4 ELITechGROUP Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022)
  • 11.3.5 ELITechGROUP Mycoplasma Testing in Clinical SWOT Analysis
  • 11.3.6 ELITechGROUP Recent Developments
• 11.4 Bio-Rad Laboratories, Inc.
  • 11.4.1 Bio-Rad Laboratories, Inc. Company Details
  • 11.4.2 Bio-Rad Laboratories, Inc. Business Overview
  • 11.4.3 Bio-Rad Laboratories, Inc. Mycoplasma Testing in Clinical Products and Services
  • 11.4.4 Bio-Rad Laboratories, Inc. Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022)
  • 11.4.5 Bio-Rad Laboratories, Inc. Mycoplasma Testing in Clinical SWOT Analysis
  • 11.4.6 Bio-Rad Laboratories, Inc. Recent Developments
• 11.5 Eurofins Scientific
  • 11.5.1 Eurofins Scientific Company Details
  • 11.5.2 Eurofins Scientific Business Overview
  • 11.5.3 Eurofins Scientific Mycoplasma Testing in Clinical Products and Services
  • 11.5.4 Eurofins Scientific Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022)
  • 11.5.5 Eurofins Scientific Mycoplasma Testing in Clinical SWOT Analysis
  • 11.5.6 Eurofins Scientific Recent Developments
• 11.6 Minerva Biolabs
  • 11.6.1 Minerva Biolabs Company Details
  • 11.6.2 Minerva Biolabs Business Overview
  • 11.6.3 Minerva Biolabs Mycoplasma Testing in Clinical Products and Services
  • 11.6.4 Minerva Biolabs Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022)
  • 11.6.5 Minerva Biolabs Mycoplasma Testing in Clinical SWOT Analysis
  • 11.6.6 Minerva Biolabs Recent Developments
• 11.7 Charles River
  • 11.7.1 Charles River Company Details
  • 11.7.2 Charles River Business Overview
  • 11.7.3 Charles River Mycoplasma Testing in Clinical Products and Services
  • 11.7.4 Charles River Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022)
  • 11.7.5 Charles River Mycoplasma Testing in Clinical SWOT Analysis
  • 11.7.6 Charles River Recent Developments
• 11.8 Clongen Laboratories
  • 11.8.1 Clongen Laboratories Company Details
  • 11.8.2 Clongen Laboratories Business Overview
  • 11.8.3 Clongen Laboratories Mycoplasma Testing in Clinical Products and Services
  • 11.8.4 Clongen Laboratories Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022)
  • 11.8.5 Clongen Laboratories Mycoplasma Testing in Clinical SWOT Analysis
  • 11.8.6 Clongen Laboratories Recent Developments
• 11.9 BioFire Diagnostics
  • 11.9.1 BioFire Diagnostics Company Details
  • 11.9.2 BioFire Diagnostics Business Overview
  • 11.9.3 BioFire Diagnostics Mycoplasma Testing in Clinical Products and Services
  • 11.9.4 BioFire Diagnostics Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022)
  • 11.9.5 BioFire Diagnostics Mycoplasma Testing in Clinical SWOT Analysis
  • 11.9.6 BioFire Diagnostics Recent Developments
• 11.10 PromoCell GmbH
  • 11.10.1 PromoCell GmbH Company Details
  • 11.10.2 PromoCell GmbH Business Overview
  • 11.10.3 PromoCell GmbH Mycoplasma Testing in Clinical Products and Services
  • 11.10.4 PromoCell GmbH Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022)
  • 11.10.5 PromoCell GmbH Mycoplasma Testing in Clinical SWOT Analysis
  • 11.10.6 PromoCell GmbH Recent Developments
• 11.11 Lonza
  • 11.11.1 Lonza Company Details
  • 11.11.2 Lonza Business Overview
  • 11.11.3 Lonza Mycoplasma Testing in Clinical Products and Services
  • 11.11.4 Lonza Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022)
  • 11.11.5 Lonza Recent Developments
• 11.12 Roche
  • 11.12.1 Roche Company Details
  • 11.12.2 Roche Business Overview
  • 11.12.3 Roche Mycoplasma Testing in Clinical Products and Services
  • 11.12.4 Roche Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022)
  • 11.12.5 Roche Recent Developments
• 11.13 Agilent Technologies, Inc.
  • 11.13.1 Agilent Technologies, Inc. Company Details
  • 11.13.2 Agilent Technologies, Inc. Business Overview
  • 11.13.3 Agilent Technologies, Inc. Mycoplasma Testing in Clinical Products and Services
  • 11.13.4 Agilent Technologies, Inc. Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022)
  • 11.13.5 Agilent Technologies, Inc. Recent Developments
• 11.14 Liofilchem Srl
  • 11.14.1 Liofilchem Srl Company Details
  • 11.14.2 Liofilchem Srl Business Overview
  • 11.14.3 Liofilchem Srl Mycoplasma Testing in Clinical Products and Services
  • 11.14.4 Liofilchem Srl Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022)
  • 11.14.5 Liofilchem Srl Recent Developments
• 11.15 ZEAKON Diagnostics
  • 11.15.1 ZEAKON Diagnostics Company Details
  • 11.15.2 ZEAKON Diagnostics Business Overview
  • 11.15.3 ZEAKON Diagnostics Mycoplasma Testing in Clinical Products and Services
  • 11.15.4 ZEAKON Diagnostics Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022)
  • 11.15.5 ZEAKON Diagnostics Recent Developments

12 Mycoplasma Testing in Clinical Market Dynamics

• 12.1 Mycoplasma Testing in Clinical Market Trends
• 12.2 Mycoplasma Testing in Clinical Market Drivers
• 12.3 Mycoplasma Testing in Clinical Market Challenges
• 12.4 Mycoplasma Testing in Clinical Market Restraints

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
  • 14.1.2 Data Source
• 14.2 Author Details

List of Tables

• Table 1. Global Mycoplasma Testing in Clinical Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of PCR
• Table 3. Key Players of ELSA
• Table 4. Key Players of Enzymatic Methods
• Table 5. Key Players of DNA Staining
• Table 6. Global Mycoplasma Testing in Clinical Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 7. Global Mycoplasma Testing in Clinical Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
• Table 8. Global Mycoplasma Testing in Clinical Revenue by Region (2017-2022) & (US$ Million)
• Table 9. Global Mycoplasma Testing in Clinical Revenue Market Share by Region (2017-2022)
• Table 10. Global Mycoplasma Testing in Clinical Revenue by Players (2017-2022) & (US$ Million)
• Table 11. Global Mycoplasma Testing in Clinical Market Share by Players (2017-2022)
• Table 12. Global Top Mycoplasma Testing in Clinical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycoplasma Testing in Clinical as of 2021)
• Table 13. Ranking of Global Top Mycoplasma Testing in Clinical Companies by Revenue (US$ Million) in 2021
• Table 14. Global 5 Largest Players Market Share by Mycoplasma Testing in Clinical Revenue (CR5 and HHI) & (2017-2022)
• Table 15. Key Players Headquarters and Area Served
• Table 16. Key Players Mycoplasma Testing in Clinical Product Solution and Service
• Table 17. Date of Key Manufacturers Enter into Mycoplasma Testing in Clinical Market
• Table 18. Mergers & Acquisitions, Expansion Plans
• Table 19. Global Mycoplasma Testing in Clinical Market Size by Type (2017-2022) & (US$ Million)
• Table 20. Global Mycoplasma Testing in Clinical Revenue Market Share by Type (2017-2022)
• Table 21. Global Mycoplasma Testing in Clinical Forecasted Market Size by Type (2023-2028) & (US$ Million)
• Table 22. Global Mycoplasma Testing in Clinical Revenue Market Share by Type (2023-2028)
• Table 23. Global Mycoplasma Testing in Clinical Market Size by Application (2017-2022) & (US$ Million)
• Table 24. Global Mycoplasma Testing in Clinical Revenue Market Share by Application (2017-2022)
• Table 25. Global Mycoplasma Testing in Clinical Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 26. Global Mycoplasma Testing in Clinical Revenue Market Share by Application (2023-2028)
• Table 27. North America Mycoplasma Testing in Clinical Revenue by Company (2020-2022) & (US$ Million)
• Table 28. North America Mycoplasma Testing in Clinical Revenue by Type (2017-2022) & (US$ Million)
• Table 29. North America Mycoplasma Testing in Clinical Revenue by Type (2023-2028) & (US$ Million)
• Table 30. North America Mycoplasma Testing in Clinical Revenue by Application (2017-2022) & (US$ Million)
• Table 31. North America Mycoplasma Testing in Clinical Revenue by Application (2023-2028) & (US$ Million)
• Table 32. North America Mycoplasma Testing in Clinical Revenue by Country (2017-2022) & (US$ Million)
• Table 33. North America Mycoplasma Testing in Clinical Revenue by Country (2023-2028) & (US$ Million)
• Table 34. Europe Mycoplasma Testing in Clinical Revenue by Company (2020-2022) & (US$ Million)
• Table 35. Europe Mycoplasma Testing in Clinical Revenue by Type (2017-2022) & (US$ Million)
• Table 36. Europe Mycoplasma Testing in Clinical Revenue by Type (2023-2028) & (US$ Million)
• Table 37. Europe Mycoplasma Testing in Clinical Revenue by Application (2017-2022) & (US$ Million)
• Table 38. Europe Mycoplasma Testing in Clinical Revenue by Application (2023-2028) & (US$ Million)
• Table 39. Europe Mycoplasma Testing in Clinical Revenue by Country (2017-2022) & (US$ Million)
• Table 40. Europe Mycoplasma Testing in Clinical Revenue by Country (2023-2028) & (US$ Million)
• Table 41. Asia Pacific Mycoplasma Testing in Clinical Revenue by Company (2020-2022) & (US$ Million)
• Table 42. Asia Pacific Mycoplasma Testing in Clinical Revenue by Type (2017-2022) & (US$ Million)
• Table 43. Asia Pacific Mycoplasma Testing in Clinical Revenue by Type (2023-2028) & (US$ Million)
• Table 44. Asia Pacific Mycoplasma Testing in Clinical Revenue by Application (2017-2022) & (US$ Million)
• Table 45. Asia Pacific Mycoplasma Testing in Clinical Revenue by Application (2023-2028) & (US$ Million)
• Table 46. Asia Pacific Mycoplasma Testing in Clinical Revenue by Region (2017-2022) & (US$ Million)
• Table 47. Asia Pacific Mycoplasma Testing in Clinical Revenue by Region (2023-2028) & (US$ Million)
• Table 48. Latin America Mycoplasma Testing in Clinical Revenue by Company (2020-2022) & (US$ Million)
• Table 49. Latin America Mycoplasma Testing in Clinical Revenue by Type (2017-2022) & (US$ Million)
• Table 50. Latin America Mycoplasma Testing in Clinical Revenue by Type (2023-2028) & (US$ Million)
• Table 51. Latin America Mycoplasma Testing in Clinical Revenue by Application (2017-2022) & (US$ Million)
• Table 52. Latin America Mycoplasma Testing in Clinical Revenue by Application (2023-2028) & (US$ Million)
• Table 53. Latin America Mycoplasma Testing in Clinical Revenue by Country (2017-2022) & (US$ Million)
• Table 54. Latin America Mycoplasma Testing in Clinical Revenue by Country (2023-2028) & (US$ Million)
• Table 55. Middle East and Africa Mycoplasma Testing in Clinical Revenue by Company (2020-2022) & (US$ Million)
• Table 56. Middle East and Africa Mycoplasma Testing in Clinical Revenue by Type (2017-2022) & (US$ Million)
• Table 57. Middle East and Africa Mycoplasma Testing in Clinical Revenue by Type (2023-2028) & (US$ Million)
• Table 58. Middle East and Africa Mycoplasma Testing in Clinical Revenue by Application (2017-2022) & (US$ Million)
• Table 59. Middle East and Africa Mycoplasma Testing in Clinical Revenue by Application (2023-2028) & (US$ Million)
• Table 60. Middle East and Africa Mycoplasma Testing in Clinical Revenue by Country (2017-2022) & (US$ Million)
• Table 61. Middle East and Africa Mycoplasma Testing in Clinical Revenue by Country (2023-2028) & (US$ Million)
• Table 62. Sartorius AG Company Details
• Table 63. Sartorius AG Business Overview
• Table 64. Sartorius AG Mycoplasma Testing in Clinical Product and Services
• Table 65. Sartorius AG Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022) & (US$ Million)
• Table 66. Sartorius AG Mycoplasma Testing in Clinical SWOT Analysis
• Table 67. Sartorius AG Recent Developments
• Table 68. MERCK KGAA Company Details
• Table 69. MERCK KGAA Business Overview
• Table 70. MERCK KGAA Mycoplasma Testing in Clinical Product and Services
• Table 71. MERCK KGAA Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022) & (US$ Million)
• Table 72. MERCK KGAA Mycoplasma Testing in Clinical SWOT Analysis
• Table 73. MERCK KGAA Recent Developments
• Table 74. ELITechGROUP Company Details
• Table 75. ELITechGROUP Business Overview
• Table 76. ELITechGROUP Mycoplasma Testing in Clinical Product and Services
• Table 77. ELITechGROUP Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022) & (US$ Million)
• Table 78. ELITechGROUP Mycoplasma Testing in Clinical SWOT Analysis
• Table 79. ELITechGROUP Recent Developments
• Table 80. Bio-Rad Laboratories, Inc. Company Details
• Table 81. Bio-Rad Laboratories, Inc. Business Overview
• Table 82. Bio-Rad Laboratories, Inc. Mycoplasma Testing in Clinical Product and Services
• Table 83. Bio-Rad Laboratories, Inc. Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022) & (US$ Million)
• Table 84. Bio-Rad Laboratories, Inc. Mycoplasma Testing in Clinical SWOT Analysis
• Table 85. Bio-Rad Laboratories, Inc. Recent Developments
• Table 86. Eurofins Scientific Company Details
• Table 87. Eurofins Scientific Business Overview
• Table 88. Eurofins Scientific Mycoplasma Testing in Clinical Product and Services
• Table 89. Eurofins Scientific Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022) & (US$ Million)
• Table 90. Eurofins Scientific Mycoplasma Testing in Clinical SWOT Analysis
• Table 91. Eurofins Scientific Recent Developments
• Table 92. Minerva Biolabs Company Details
• Table 93. Minerva Biolabs Business Overview
• Table 94. Minerva Biolabs Mycoplasma Testing in Clinical Product and Services
• Table 95. Minerva Biolabs Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022) & (US$ Million)
• Table 96. Minerva Biolabs Mycoplasma Testing in Clinical SWOT Analysis
• Table 97. Minerva Biolabs Recent Developments
• Table 98. Charles River Company Details
• Table 99. Charles River Business Overview
• Table 100. Charles River Mycoplasma Testing in Clinical Product and Services
• Table 101. Charles River Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022) & (US$ Million)
• Table 102. Charles River Mycoplasma Testing in Clinical SWOT Analysis
• Table 103. Charles River Recent Developments
• Table 104. Clongen Laboratories Company Details
• Table 105. Clongen Laboratories Business Overview
• Table 106. Clongen Laboratories Mycoplasma Testing in Clinical Product and Services
• Table 107. Clongen Laboratories Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022) & (US$ Million)
• Table 108. Clongen Laboratories Mycoplasma Testing in Clinical SWOT Analysis
• Table 109. Clongen Laboratories Recent Developments
• Table 110. BioFire Diagnostics Company Details
• Table 111. BioFire Diagnostics Business Overview
• Table 112. BioFire Diagnostics Mycoplasma Testing in Clinical Product and Services
• Table 113. BioFire Diagnostics Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022) & (US$ Million)
• Table 114. BioFire Diagnostics Mycoplasma Testing in Clinical SWOT Analysis
• Table 115. BioFire Diagnostics Recent Developments
• Table 116. PromoCell GmbH Company Details
• Table 117. PromoCell GmbH Business Overview
• Table 118. PromoCell GmbH Mycoplasma Testing in Clinical Product and Services
• Table 119. PromoCell GmbH Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022) & (US$ Million)
• Table 120. PromoCell GmbH Mycoplasma Testing in Clinical SWOT Analysis
• Table 121. PromoCell GmbH Recent Developments
• Table 122. Lonza Company Details
• Table 123. Lonza Business Overview
• Table 124. Lonza Mycoplasma Testing in Clinical Product and Services
• Table 125. Lonza Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022) & (US$ Million)
• Table 126. Lonza Recent Developments
• Table 127. Roche Company Details
• Table 128. Roche Business Overview
• Table 129. Roche Mycoplasma Testing in Clinical Product and Services
• Table 130. Roche Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022) & (US$ Million)
• Table 131. Roche Recent Developments
• Table 132. Agilent Technologies, Inc. Company Details
• Table 133. Agilent Technologies, Inc. Business Overview
• Table 134. Agilent Technologies, Inc. Mycoplasma Testing in Clinical Product and Services
• Table 135. Agilent Technologies, Inc. Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022) & (US$ Million)
• Table 136. Agilent Technologies, Inc. Recent Developments
• Table 137. Liofilchem Srl Company Details
• Table 138. Liofilchem Srl Business Overview
• Table 139. Liofilchem Srl Mycoplasma Testing in Clinical Product and Services
• Table 140. Liofilchem Srl Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022) & (US$ Million)
• Table 141. Liofilchem Srl Recent Developments
• Table 142. ZEAKON Diagnostics Company Details
• Table 143. ZEAKON Diagnostics Business Overview
• Table 144. ZEAKON Diagnostics Mycoplasma Testing in Clinical Product and Services
• Table 145. ZEAKON Diagnostics Mycoplasma Testing in Clinical Revenue in Mycoplasma Testing in Clinical Business (2017-2022) & (US$ Million)
• Table 146. ZEAKON Diagnostics Recent Developments
• Table 147. Mycoplasma Testing in Clinical Market Trends
• Table 148. Mycoplasma Testing in Clinical Market Drivers
• Table 149. Mycoplasma Testing in Clinical Market Challenges
• Table 150. Mycoplasma Testing in Clinical Market Restraints
• Table 151. Research Programs/Design for This Report
• Table 152. Key Data Information from Secondary Sources
• Table 153. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Mycoplasma Testing in Clinical Sales Market Share by Type: 2021 VS 2028
• Figure 2. PCR Features
• Figure 3. ELSA Features
• Figure 4. Enzymatic Methods Features
• Figure 5. DNA Staining Features
• Figure 6. Global Mycoplasma Testing in Clinical Sales Market Share by Application: 2021 VS 2028
• Figure 7. Cell Line Testing Case Studies
• Figure 8. Virus Testing Case Studies
• Figure 9. Others Case Studies
• Figure 10. Mycoplasma Testing in Clinical Report Years Considered
• Figure 11. Global Mycoplasma Testing in Clinical Revenue, (US$ Million), 2017 VS 2021 VS 2028
• Figure 12. Global Mycoplasma Testing in Clinical Market Size 2017-2028 (US$ Million)
• Figure 13. Global Mycoplasma Testing in Clinical Market Size Market Share by Region: 2021 VS 2028
• Figure 14. Global Mycoplasma Testing in Clinical Revenue Market Share by Region in 2017 VS 2022
• Figure 15. Global Top 10 Mycoplasma Testing in Clinical Countries Ranking by Market Size (US$ Million) in 2021
• Figure 16. Global Mycoplasma Testing in Clinical Market Share by Players in 2021
• Figure 17. Global Top Mycoplasma Testing in Clinical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycoplasma Testing in Clinical as of 2021)
• Figure 18. The Top 10 and 5 Players Market Share by Mycoplasma Testing in Clinical Revenue in 2021
• Figure 19. North America Mycoplasma Testing in Clinical Revenue Market Share by Company in 2021
• Figure 20. North America Mycoplasma Testing in Clinical Revenue Market Share by Type (2017-2028)
• Figure 21. North America Mycoplasma Testing in Clinical Revenue Market Share by Application (2017-2028)
• Figure 22. North America Mycoplasma Testing in Clinical Revenue Share by Country (2017-2028)
• Figure 23. U.S. Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 24. Canada Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 25. Europe Mycoplasma Testing in Clinical Revenue Market Share by Company in 2021
• Figure 26. Europe Mycoplasma Testing in Clinical Revenue Market Share by Type (2017-2028)
• Figure 27. Europe Mycoplasma Testing in Clinical Revenue Market Share by Application (2017-2028)
• Figure 28. Europe Mycoplasma Testing in Clinical Revenue Share by Country (2017-2028)
• Figure 29. Germany Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 30. France Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 31. U.K. Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 32. Italy Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 33. Russia Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 34. Asia Pacific Mycoplasma Testing in Clinical Revenue Market Share by Company in 2021
• Figure 35. Asia Pacific Mycoplasma Testing in Clinical Revenue Market Share by Type (2017-2028)
• Figure 36. Asia Pacific Mycoplasma Testing in Clinical Revenue Market Share by Application (2017-2028)
• Figure 37. Asia Pacific Mycoplasma Testing in Clinical Revenue Share by Region (2017-2028)
• Figure 38. China Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 39. Japan Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 40. South Korea Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 41. India Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 42. Australia Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 43. Taiwan Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 44. Indonesia Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 45. Thailand Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 46. Malaysia Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 47. Philippines Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 48. Vietnam Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 49. Latin America Mycoplasma Testing in Clinical Revenue Market Share by Company in 2021
• Figure 50. Latin America Mycoplasma Testing in Clinical Revenue Market Share by Type (2017-2028)
• Figure 51. Latin America Mycoplasma Testing in Clinical Revenue Market Share by Application (2017-2028)
• Figure 52. Latin America Mycoplasma Testing in Clinical Revenue Share by Country (2017-2028)
• Figure 53. Mexico Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 54. Brazil Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 55. Argentina Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 56. Middle East and Africa Mycoplasma Testing in Clinical Revenue Market Share by Company in 2021
• Figure 57. Middle East and Africa Mycoplasma Testing in Clinical Revenue Market Share by Type (2017-2028)
• Figure 58. Middle East and Africa Mycoplasma Testing in Clinical Revenue Market Share by Application (2017-2028)
• Figure 59. Middle East and Africa Mycoplasma Testing in Clinical Revenue Share by Country (2017-2028)
• Figure 60. Turkey Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 61. Saudi Arabia Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 62. U.A.E Mycoplasma Testing in Clinical Revenue (2017-2028) & (US$ Million)
• Figure 63. Sartorius AG Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2017-2022)
• Figure 64. MERCK KGAA Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2017-2022)
• Figure 65. ELITechGROUP Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2017-2022)
• Figure 66. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2017-2022)
• Figure 67. Eurofins Scientific Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2017-2022)
• Figure 68. Minerva Biolabs Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2017-2022)
• Figure 69. Charles River Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2017-2022)
• Figure 70. Clongen Laboratories Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2017-2022)
• Figure 71. BioFire Diagnostics Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2017-2022)
• Figure 72. PromoCell GmbH Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2017-2022)
• Figure 73. Lonza Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2017-2022)
• Figure 74. Roche Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2017-2022)
• Figure 75. Agilent Technologies, Inc. Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2017-2022)
• Figure 76. Liofilchem Srl Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2017-2022)
• Figure 77. ZEAKON Diagnostics Revenue Growth Rate in Mycoplasma Testing in Clinical Business (2017-2022)
• Figure 78. Bottom-up and Top-down Approaches for This Report
• Figure 79. Data Triangulation
• Figure 80. Key Executives Interviewed